Aleta Biotherapeutics
MA - NatickBiotechnology
Focus: Aleta Biotherapeutics is a cell therapy-focused biotech company headquartered in Natick, MA, founded in 2013 and operating as a public entity. The company specializes in gene therapy and cell therapy modalities for oncology and other serious diseases.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Aleta Biotherapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Aleta Biotherapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ALETA-001
Lymphoma, Non-HodgkinClinical Trials (1)
NCT06045910A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
Phase 1/2Help build intelligence for Aleta Biotherapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.